Full Professor of Respiratory Medicine at the University of Pisa, and Chief of the Respiratory Pathophysiology and Pulmonary Rehabilitation Unit of the University Hospital of Pisa, up to November 2018. Graduated in Medicine and Surgery at the University of Pisa in 1972, He post-graduated in Occupational Medicine (1974), Respiratory Medicine (1977) and Allergy and Clinical Immunology (1981). Post-doctoral fellowships at the University of British Columbia (Vancouver, Canada, 1985 and 1987) and at the S. Francisco General Hospital (S. Francisco, Ca, USA, 1989). Research fields: pathophysiology and therapy of asthma and COPD, occupational asthma, airway pharmacology, pulmonary rehabilitation. Co-authors of 320 papers on peer-review journals, on the topics of asthma and COPD. Principal investigator of several phase 2-phase 3 clinical trials in asthma, COPD and bronchiectasis, and director of several research projects funded by Italian Ministry of Health, Italian Agency of the Drug (AIFA), Tuscany Region and pharmaceutical companies. Between 2005 and 2015, He was member of the Board of Directors of GINA International, and Chairman of the GINA Mediterranean Initiative. Up to now, He is the Chairman of the GINA Italy Initiative. He is a fellow of European Respiratory Society.

Alberto Papi is Professor of Respiratory Medicine at the University of Ferrara, Italy, and Director of the Respiratory Unit of the Department of Emergency Medicine, S. Anna University Hospital, Ferrara, Italy. He trained in respiratory medicine at the University of Parma before spending 4 years in the United Kingdom as a Clinical Research Fellow at the University of Southampton, where he is an Honorary Clinical Lecturer. His department is also home to the Research Centre on Inflammatory and Smoking-related Respiratory Diseases (CEMICEF). Professor Papi’s main area of research focus is on understanding the mechanisms and treatment of asthma and COPD, especially of airway inflammation and its molecular mechanisms and pharmacological modulation. One of the major scientific interests is the role of respiratory viral infections in stable/exacerbated obstructive lung diseases and the underlying molecular inflammatory and immunological mechanisms. He has also been investigating the role of noninvasive measurements of airway inflammation in characterizing specific populations of patients with obstructive lung diseases. Professor Papi has previously served as a member of the Asthma Board of the European Academy of Allergy and Clinical Immunology, and Secretary of the Respiratory Infections Group of the European Respiratory Society. He is also a member of the Editorial Board of the American Journal of Respiratory and Critical Care Medicine, Asthma Research and Practice, and the Journal of COPD. He has coordinated several pivotal studies in asthma and COPD and has authored more than 350 articles in peer-reviewed journals.

Dr. Patel is the Director of Bronchoscopy at Ascension St. Vincent Indianapolis and he has a special interest in lung cancer, lung nodules and complex airway diseases. He oversees the Lung Nodule Clinic and Lung Cancer Screening program. In addition, Dr. Patel has expertise in robotic bronchoscopy, endobronchial ultrasound bronchoscopy (EBUS), cryotherapy, airway thermal therapy, endobronchial valve placement for COPD, bronchial thermoplasty for asthma, stent placement and tunneled pleural catheters.

Girolamo Pelaia works at “Magna Graecia” University of Catanzaro, Italy, where he is Full Professor of Pulmonary Medicine, Director of the Postdoctoral Specialization School of Respiratory Diseases, and Head of the Respiratory Disease Unit. Moreover, he currently holds the position of Chest Global Governor for Italy. He was born on 15 August 1960 in Catanzaro, Italy. In 1985 he received a degree in Medicine and Surgery, with distinction (“summa cum laude”), from the University of Reggio Calabria, Italy, and in 1989 he graduated with distinction (“summa cum laude”) as a Specialist in Respiratory Diseases at the University of Naples “Federico II”, Italy. He subsequently worked from 1990 to 1992 as a Postdoctoral Fellow at Georgetown University School of Medicine, Washington, D.C., USA. The clinical and research activities of Professor Pelaia primarily deal with the pathophysiology and treatment of asthma and chronic obstructive pulmonary disease (COPD). In particular, he is interested in the cellular and molecular mechanisms underlying the therapeutic effects of inhaled corticosteroids, long-acting bronchodilators, and anti-asthma biologic drugs. He has authored or co-authored more than 130 original articles and reviews published in international peer-reviewed journals, as well as several book chapters.

1. Thoracic Surgeon from National Institute of Respiratory Disease. México City 2. DUKE University Supervised Stay. Durham NC 3. Minimally Invasive Thoracic Surgery National Institute of Medical Science and Nutrition Salvador Zubiran. México City 4. Chief of Thoracic and Trachea Surgery National Institute of Medical Science and Nutrition "Salvador Zubiran". México City

CURRICULUM VITAE Venerino Poletti, born in Bagnacavallo (RA, Italy) in December, 28th, 1956. Medical Degree University of Bologna cum Laude, 1981 Specialization in Pulmonary Medicine University of Bologna cum Laude, 1985 Specialization in Anatomic Pathology University of Bologna cum Laude, 1989 Head Pulmonology Department GB Morgagni Hospital, 2001-today Head Department Diseases of the Thorax Azienda USL Romagna, 2015-today “Professore a Contratto” Pulmonary Medicine University of Bologna/University of Parma ((I)-1996 2014 Full Professor Pulmonary Medicine & Chair Aarhus University , Aarhus (DK) 2015-2020 Honorary Professor Pulmonary Medicine Aarhus University , Aarhus (DK) 2020-today Full Professor Pulmonary Medicine Bologna University 2021-today Head of Assembly 12, European Respiratory Society 2018-2021. President Italian Thoracic Society (AIPO) 2018-2019. Past President Italian Thoracic Society 2020-2021. Pubblication in PubMed 344; H Index (Scopus) 52; H Index (Google Scholar) 63. Research Interests: Pulmonary Pathology, Interventional Pulmonology, Diffuse Parenchymal Lung Diseases

Dr. Polverino currently is responsible for the Outpatient Clinics and surveillance service of non-cystic fibrosis bronchiectasis (NCFBE) and community-acquired pneumonia (CAP) at Hospital Clinic (Barcelona), and she is now working at Hospital Vall D’Hebron in the cystic fibrosis (CF) and NCFBE Unit and is senior investigator in respiratory infection at Vall D’Hebron Instuitut de Recerca (VHIR). She has gained particular experience in promoting and leading collaborative research across different countries and centers, in scientific communication, and in educational activities. Dr. Polverino’s main lines of investigation currently are: NCFBE; CF; immunodeficiencies and respiratory diseases; CAP, and health-care-associated pneumonia (HCAP).